Funding for this research was provided by:
Agence Nationale de la Recherche (ANR_15-RHUS60002)
Article History
Received: 5 September 2020
Accepted: 27 November 2020
First Online: 10 December 2020
Ethics approval and consent to participate
: All experimental procedures were performed in accordance with the European Community Council Directive (2010/63/UE) for the care and use of laboratory animals. Experimental protocols were approved by the local ethics committee “Comité d’éthique en expérimentation animal Charles Darwin N<sup>°</sup>5” under the number 02811.03 in compliance with European Union guidelines.
: Not applicable
: Dr. Sina Naserian is the CEO of CellMedEx Company.The rest of the authors declare that they have no competing interests.